 BURNABY, British Columbia, Nov. 13, 2020 GLOBE NEWSWIRE -- Xenon Pharmaceuticals Inc. Nasdaq:XENE, a clinical stage biopharmaceutical company, today announced that Dr. Simon Pimstone, Xenons Chief Executive Officer, will participate in the following virtual investor conferences: 